Related Experiment Video
Updated: Aug 11, 2026
Isolation of Macrophage Subsets and Stromal Cells from Human and Mouse Myocardial Specimens
Published on: December 17, 2019
Granulocyte Macrophage-Colony Stimulating Factor receptor expression on human cardiomyocytes from end-stage heart
Loredana Postiglione1, Stefania Montagnani, Paolo Ladogana
1Department of Cellular and Molecular Biology and Pathology "L. Califano", "Federico II" University, Via S. Pansini, 5, Ed. 19, 80131 Naples, Italy.
Insights
Heart failure involves ventricular remodeling and changes in extracellular matrix. Researchers found increased Granulocyte Macrophage-Colony Stimulating Factor receptor (GM-CSFR) in failing human hearts, suggesting a role in cardiac regeneration.
Area of Science:
- Cardiovascular Biology
- Regenerative Medicine
- Molecular Cardiology
Background:
- Heart failure progression involves ventricular remodeling, extracellular matrix (ECM) changes, and cardiomyocyte damage.
- Cytokines and growth factors influence cardiac tissue repair after injury.
- While myocytes were considered terminally differentiated, evidence suggests they can proliferate.
Purpose of the Study:
- To investigate Granulocyte Macrophage-Colony Stimulating Factor receptor (GM-CSFR) expression in healthy and failing human hearts.
- To evaluate the potential role of GM-CSF and its receptor in cardiac tissue regeneration in chronic cardiomyopathy.
Main Methods:
- Immunohistochemistry was used to analyze GM-CSFR expression in human cardiac tissue.
- Samples included explanted hearts from end-stage heart failure patients and biopsies from normal hearts.
- Cellular and molecular biology assays were also performed.
Main Results:
- GM-CSFR expression was significantly increased in cardiomyocytes from end-stage heart failure tissues compared to normal controls.
- This finding indicates altered receptor levels in diseased myocardium.
Conclusions:
- The study hypothesizes a role for GM-CSF in myocardial processes.
- These processes include apoptosis, extracellular matrix deposition, and cytoskeleton modification.
- GM-CSF signaling may be implicated in the pathophysiology of heart failure.
Background:
In remodelling ventricles, the progression of heart failure is associated with structural changes involving the extra-cellular matrix (ECM) and the cytoskeleton of cardiomyocytes, associated with fibrosis, cellular damage and death. The role of some cytokines and haematopoietic growth factors in the mechanism of both damage and regeneration of cardiac tissue during acute myocardial infarction has been demonstrated. Following heart damage, the development of scarred tissue was considered to be the only outcome, since myocytes were considered to be terminally differentiated cells. However, recent studies in animal models and adult human hearts have shown that myocytes can proliferate under the modulation of several factors.
Aims:
To assess Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF) receptor expression in healthy and diseased human hearts, and to evaluate the possible role of GM-CSF and its receptor in the regeneration of cardiac tissue in chronic cardiomyopathy.
Methods And Results:
GM-CSFR expression in human cardiac tissue from explanted hearts of ten patients with end-stage heart failure and in cardiac biopsies from eight normal human hearts was studied by immunohistochemistry, and cellular and molecular biology assays. Our results demonstrated an increase in GM-CSFR in cardiomyocytes from end-stage heart failure tissues as compared to normal control tissues.
Conclusions:
We hypothesize that GM-CSF plays a role in apoptotic and/or ECM deposition processes as well as in cytoskeleton modification in the myocardium.
